| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Xebio Holdings Co Ltd
Xebio Holdings Co Ltd
TSE:8281
Xebio Holdings Co Ltd
Cash Equivalents
Xebio Holdings Co Ltd
Cash Equivalents Peer Comparison
8136
3046
2780
2681
3028
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Xebio Holdings Co Ltd
TSE:8281
|
Cash Equivalents
¥24.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Sanrio Co Ltd
TSE:8136
|
Cash Equivalents
¥90.4B
|
CAGR 3-Years
35%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
Jins Holdings Inc
TSE:3046
|
Cash Equivalents
¥13.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
18%
|
|
|
Komehyo Holdings Co Ltd
TSE:2780
|
Cash Equivalents
¥15.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
21%
|
|
|
Geo Holdings Corp
TSE:2681
|
Cash Equivalents
¥45.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
Alpen Co Ltd
TSE:3028
|
Cash Equivalents
¥9.5B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
See Also
What is Xebio Holdings Co Ltd's Cash Equivalents?
Cash Equivalents
24.9B
JPY
Based on the financial report for Mar 31, 2024, Xebio Holdings Co Ltd's Cash Equivalents amounts to 24.9B JPY.
What is Xebio Holdings Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
1%
Over the last year, the Cash Equivalents growth was -24%. The average annual Cash Equivalents growth rates for Xebio Holdings Co Ltd have been -17% over the past three years , 6% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
